Over-expression of CXCR4 has been identified as a promising prognostic biomarker for gastrointestinal and acute myeloid leukemia, among many other tumor types (Du et al., 2019; Jiang et al., 2019). The gene discussed is CXCR4; the disease is acute myeloid leukemia.